APA (7th ed.) Citation

Nutman, A., Temkin, E., Lellouche, J., Amar Ben Dalak, M., Kaplan, E., Lurie-Weinberger, M., . . . Leibovici, L. (2025). Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: Findings from the AIDA randomized trial. Antimicrobial Resistance & Infection Control, 14(1), 1. https://doi.org/10.1186/s13756-025-01651-1

Chicago Style (17th ed.) Citation

Nutman, Amir, et al. "Carbapenem-resistant Enterobacterales (CRE) Acquisition and Molecular Characterization Following Colistin Monotherapy and Colistin-meropenem Combination Therapy: Findings from the AIDA Randomized Trial." Antimicrobial Resistance & Infection Control 14, no. 1 (2025): 1. https://doi.org/10.1186/s13756-025-01651-1.

MLA (9th ed.) Citation

Nutman, Amir, et al. "Carbapenem-resistant Enterobacterales (CRE) Acquisition and Molecular Characterization Following Colistin Monotherapy and Colistin-meropenem Combination Therapy: Findings from the AIDA Randomized Trial." Antimicrobial Resistance & Infection Control, vol. 14, no. 1, 2025, p. 1, https://doi.org/10.1186/s13756-025-01651-1.